Patents
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
12/2007
12/18/2007US7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/13/2007WO2007142207A1 Process for production of 4-substituted azetidinone derivatives
12/12/2007CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
12/06/2007WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007WO2007068894A3 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
12/06/2007CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c
12/05/2007EP1862455A2 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-undecanoic acid
12/05/2007CN100352818C Improved method of preparing azhediping
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
11/2007
11/29/2007WO2007136326A2 ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3
11/29/2007WO2007136325A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 2
11/29/2007WO2007106329A3 Low pressure carbonylation of heterocycles
11/29/2007US20070275909 Useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels; carbohydrate-containing pyrazolidinone or oxazolidinone derivatives, for example
11/28/2007EP1859796A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
11/22/2007WO2007133624A2 A device and method to synchronize the motion of two robots that have independent control systems
11/21/2007EP1856035A1 Process for preparaing protected amiidines
11/21/2007EP1856032A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007CN100350036C Apparatus and method for controlling biofilms
11/20/2007US7297788 Regioselective hydroxylation, functionalisation and protection of spirolactams
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265243 Antibiotic-Bound Poly(Caprolactone) Polymer
11/15/2007US20070265242 Novel Carbapenem Compound
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/08/2007WO2007126358A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit.
11/08/2007US20070259848 N-({[1-(3,4-Dichloro-benzyl)-azetidin-3-ylmethyl]-carbamoyl}-methyl)-2-methoxy-benzamide; inflammatory or allergic condition such as an inflammatory or obstructive airways disease
11/08/2007US20070259845 Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe
11/08/2007CA2649363A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitor activity
11/07/2007EP1851197A2 Phenylazetidinone derivatives
11/06/2007US7291728 Spirolactams and their synthesis
11/01/2007WO2007122488A2 Radiofluorinated compounds and their preparation
10/2007
10/31/2007EP1756049B1 Method for producing 1,4-diphenyl azetidinone derivatives
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007CN101065354A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007US20070249816 Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2634648A1 Processes for preparing intermediate compounds useful for the preparation of ezetimibe
10/24/2007CN101058556A Diphenylacetidinon derivatives for treatment of disordered lipid metabolism, method of production thereof(variants), pharmaceutical composition
10/18/2007WO2007116230A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007US20070244084 Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide
10/18/2007CA2648687A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/17/2007EP1843767A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
10/17/2007CN101054376A Method of preparing 1-methyl carbon cephem and intermediate product thereof
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/03/2007CN101048369A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
09/2007
09/27/2007WO2007108007A1 A process for the preparation of ezetimibe via a novel intermediate
09/27/2007US20070225296 Arylalkylamine Compound and Process for Preparing the Same
09/25/2007US7273858 Salts
09/20/2007WO2007106329A2 Low pressure carbonylation of heterocycles
09/20/2007US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors
09/19/2007CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
09/19/2007CN101039903A Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide
09/19/2007CN100338050C Amine acid salt compounds and process for the production thereof
09/18/2007US7271289 4'-(azetidin-1-ylcarbonyl)-N-cyclopropyl-5-fluoro-6-methyl-1,1'-biphenyl-3-carboxamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
09/18/2007US7271130 N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides
09/13/2007US20070213524 Reacting an oxirane with carbon monoxide (pressure < 125 psi) to yield a beta lactone; using a catalyst comprising a chromiuim complex of a (2-hydroxyphenyl)imino(1,2-phenylene)imino-)phenol having ligands of tetrahydrofuran and cobalt tetracarbonyl; lactonization; chemical ring expansion;glass reactor
09/12/2007EP1832576A1 4-Biarylyl-1-phenolyzetidin-2-ones
09/12/2007EP1831162A1 Process for the synthesis of azetidinones
09/12/2007EP1613304B1 Dpp-iv inhibitors
09/11/2007US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
09/07/2007WO2007098651A1 USAGE OF POLY-3-HYDROXYALKANOATES IN PREPARATION OF β-LACTAM COMPOUNDS
09/06/2007US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
09/06/2007US20070208172 Process for Preparing Cephalosporin Intermediates Using Alpha-Iodo-1-Azetidineacetic Acid Esters and Trialkylphosphites
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/06/2007US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/04/2007US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
08/2007
08/30/2007WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors
08/30/2007US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors
08/30/2007DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
08/29/2007CN101027278A Preparation of beta-amino acids having affinity for the alpha-2-delta protein
08/28/2007US7262308 Resolution agent free; chemical intermediates for production of
08/28/2007CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them
08/23/2007WO2007094480A1 Method of producing optically active alcohol
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007US20070197516 modulators of monocyte chemotactic proteins (MCP-1), such as N-(2-(((S)-1-((2S,3S)-3-hydroxy-1-(isobutylamino)hexan-2-yl)-2-oxopyrrolidin-3-yl)carbamoyl)-4-(trifluoromethyl)phenyl)azetidine-1-carboxamide, useful for the prevention of asthma, multiple sclerosis, atherosclerosis and rheumatoid arthritis
08/23/2007US20070197498 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents
08/23/2007CA2642388A1 Process for preparing optically active alcohols
08/22/2007EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/21/2007US7259158 Naphthaline derivatives as H3 inverse agonists
08/16/2007WO2007091046A1 Chemical compounds
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1817280A1 Ezetimibe polymorphs
08/15/2007EP1322596B1 Zwitterionic tachykinin receptor antagonists
08/14/2007US7257287 Optical interleaver
08/14/2007US7256186 Alzheimer's disease, or other diseases relating to amyloid deposits; neurodegenerative diseases
08/08/2007EP1814885A2 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
08/08/2007EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/08/2007EP1682499B1 4-biarylyl-1-phenylazetidin-2-ones
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 69